AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients

Methotrexate (MTX) is the first-line therapy for rheumatoid arthritis. Nevertheless, MTX resistance is quite a common issue in clinical practice. There are some premises that aryl hydrocarbon receptor (AhR) gene battery may take part in MTX metabolism. In the present retrospective study, we analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wajda, Anna, Walczuk, Ewa, Stypińska, Barbara, Lach, Jakub, Yermakovich, Danat, Sivitskaya, Larysa, Romanowska-Próchnicka, Katarzyna, Wysocki, Tomasz, Jarończyk, Małgorzata, Paradowska-Gorycka, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455325/
https://www.ncbi.nlm.nih.gov/pubmed/34302046
http://dx.doi.org/10.1038/s41397-021-00238-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455325/
https://www.ncbi.nlm.nih.gov/pubmed/34302046
http://dx.doi.org/10.1038/s41397-021-00238-4

Ejemplares similares